Indication

Kaposi's sarcoma skin lesion

A Kaposi's sarcoma skin lesion is a primary cutaneous manifestation of Kaposi sarcoma, a multifocal angioproliferative neoplasm driven by infection with human herpesvirus 8 (HHV-8/KSHV). Read more about Kaposi's sarcoma skin lesion

4 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Kaposi's sarcoma skin lesion therapies.

Showing 1–4 of 4 drugs

Filter & compare in the drug finder →Opens the drug finder with Kaposi's sarcoma skin lesion preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Kaposi's sarcoma skin lesion.

A Kaposi's sarcoma skin lesion is a primary cutaneous manifestation of Kaposi sarcoma, a multifocal angioproliferative neoplasm driven by infection with human herpesvirus 8 (HHV-8/KSHV).

It primarily impacts the integumentary system, most commonly arising in immunocompromised populations—such as individuals with advanced HIV infection or organ transplant recipients—as well as older Mediterranean or Eastern European men and endemic populations in Africa.

Clinically, these lesions present as solitary or multiple non-blanching macules, patches, plaques, or nodular tumors that are typically red, purple, brown, or violaceous.

Pathophysiologically, they are characterized by aberrant angiogenesis, spindle-shaped endothelial cell proliferation, extravasated erythrocytes, and intracellular or interstitial hemosiderin deposition.

Personalize your experience

Follow Kaposi's sarcoma skin lesion and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it